$VTVT

$25.81 +$0.26 (1.02%) Close

$VTVT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 4.0M shares outstanding

Who owns VTVT?

By type of holder

Institutions 40.5% Insiders 3.4% Everyone else 56.1%

Concentration Top 10 holders own 57.6%

Srinivas Akkaraju 10.2% · Samsara Biocapital, LLC 7.6%

Institutional ownership

40.5%

+2.8 pts vs last qtr

Institutional holders

+9 vs last qtr

Net shares bought

+111.8K

by institutions in Q2 2026

New / sold out

16 / 7

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Millennium Management LLC +63.6K
Aisling Capital Management LP NEW +50.0K

Biggest sellers in Q2 2026

Trails Edge Capital Partners, LP −54.4K
683 Capital Management, LLC SOLD OUT −16.0K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for vTv Therapeutics Inc in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for vTv Therapeutics Inc.

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years55% Under 1 year45%

Quarterly turnover

12.3%

of institutional shares changed hands

Top 10 managers, median time held

1.8 years

Super Investors

Investment managers reporting VTVT on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
SB Samsara Biocapital, LLC	298.5K	7.56%	Unchanged	2023	0.9%
Shares held by quarter Peak holding374.5K (Q3'25) Change over 8 quarters+91.7K Share of the company7.560% Samsara Biocapital, LLC's full portfolio →
MM Millennium Management LLC	269.9K	6.83%	+63.6K (+30.8%)	Q1 '26	0.0%
Shares held by quarter Peak holding269.9K (Q2'26) Change over 8 quarters+269.9K Share of the company6.830% Millennium Management LLC's full portfolio →

Samsara Biocapital, LLC

298.5K

% of company

7.56%

Change vs last qtr

Unchanged

Held since

2023

Millennium Management LLC

269.9K

% of company

6.83%

Change vs last qtr

+63.6K (+30.8%)

Held since

Q1 '26

28 more super investors behind a free account

See every manager holding vTv Therapeutics Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting VTVT on Form N-PORT; together they hold 9.9% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
SB Select Biotechnology Portfolio Fidelity Select Portfolios	$8.33M	260.4K	6.59%	0.13%	August 31, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$2.29M	60.8K	1.54%	0.00%	June 30, 2026

Select Biotechnology Portfolio

Fidelity Select Portfolios

Position value

$8.33M

% of company

6.59%

% of the fund

0.13%

As of

August 31, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$2.29M

% of company

1.54%

% of the fund

0.00%

As of

June 30, 2026

13 more funds behind a free account

See every fund holding vTv Therapeutics Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
SA Srinivas Akkaraju 5%+ holder 13D · 9.9%	403.9K	10.23%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company10.230% Disclosed stake13D · 9.9% View the 13D/G filing →
SB Samsara BioCapital GP, LLC 5%+ holder 13D · 6.2%	246.5K	6.24%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company6.240% Disclosed stake13D · 6.2% View the 13D/G filing →

Srinivas Akkaraju

5%+ holder13D · 9.9%

403.9K

% of company

10.23%

Change vs last qtr

—

Held since

—

Samsara BioCapital GP, LLC

5%+ holder13D · 6.2%

246.5K

% of company

6.24%

Change vs last qtr

—

Held since

—

2 more holders behind a free account

See every insider and 5%+ holder of vTv Therapeutics Inc.

Comments